(Q33724232)

28 July 2017

1 reference

title

Drug-surfactant-propellant interactions in HFA-formulations (English)

1 reference

28 July 2017

Vervaet C

1

1 reference

28 July 2017

Byron PR

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

International Journal of Pharmaceutics

28 July 2017

published in

1 reference

28 July 2017

volume

186

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

13-30

1 reference

The quantitative determination of aspirin and its degradation products in a model solution aerosol

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Dosing reproducibility from experimental albuterol suspension metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Low first-spray drug content in albuterol metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Metered dose inhalers III: Metaproterenol sulphate; particle size distribution and dose uniformity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Determination of drug solubility in aerosol propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

The effect of solubilized water on the size and shape of lecithin micelles in an apolar solvent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

THEORY OF COARSE SUSPENSION FORMULATION.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Metered-dose inhalers, I: Drug content and particle size distribution of beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Influence of Formulation on Aerosol Particle Size

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Phospholipid-based reverse micelles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2899%2900134-9

7 January 2021

10.1016/S0378-5173(99)00134-9

Identifiers

DOI

1 reference

28 July 2017

1 reference